Loading clinical trials...
Loading clinical trials...
To investigate if renal impairment will have an impact on the pharmacokinetics of nalmefene
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
H. Lundbeck A/S
NCT07154901 · Renal Impairment
NCT07165015 · Renal Impairment, Healthy, and more
NCT07551570 · Renal Impairment
NCT06693765 · Renal Impairment, End-stage Kidney Disease, and more
NCT06352411 · Healthy, Renal Impairment
DE801
Munich
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions